Zhejiang DiAn Diagnostics Co (300244) - Total Assets

Latest as of March 2026: CN¥14.08 Billion CNY ≈ $2.06 Billion USD

Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) holds total assets worth CN¥14.08 Billion CNY (≈ $2.06 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Zhejiang DiAn Diagnostics Co (300244) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Zhejiang DiAn Diagnostics Co - Total Assets Trend (2008–2025)

This chart illustrates how Zhejiang DiAn Diagnostics Co's total assets have evolved over time, based on quarterly financial data. Explore how much of Zhejiang DiAn Diagnostics Co's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Zhejiang DiAn Diagnostics Co - Asset Composition Analysis

Current Asset Composition (December 2025)

Zhejiang DiAn Diagnostics Co's total assets of CN¥14.08 Billion consist of 75.3% current assets and 24.7% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	14.6%
Accounts Receivable	CN¥5.94 Billion	41.2%
Inventory	CN¥1.55 Billion	10.7%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥56.31 Million	0.4%
Goodwill	CN¥386.02 Million	2.7%

Asset Composition Trend (2008–2025)

This chart illustrates how Zhejiang DiAn Diagnostics Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zhejiang DiAn Diagnostics Co market cap and net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Zhejiang DiAn Diagnostics Co's current assets represent 75.3% of total assets in 2025, a decrease from 75.8% in 2008.
Cash Position: Cash and equivalents constituted 14.6% of total assets in 2025, up from 12.4% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2008.
Asset Diversification: The largest asset category is accounts receivable at 41.2% of total assets.

Zhejiang DiAn Diagnostics Co Competitors by Total Assets

Key competitors of Zhejiang DiAn Diagnostics Co based on total assets are shown below.

Company	Country	Total Assets
Fleury S.A. SA:FLRY3	Brazil	R$13.33 Billion
Wuhan Thalys Med Tech Co Ltd SHG:603716	China	CN¥1.74 Billion
Spectral Med Inc TO:EDT	Canada	CA$8.12 Million
Bcal Diagnostics Ltd AU:BDX	Australia	AU$7.17 Million
Genetic Signatures Ltd AU:GSS	Australia	AU$49.04 Million
ALPHAHELIX MOL.DIAGN. SK1 F:4MB	Germany	€13.12 Million
Sonic Healthcare Ltd AU:SHL	Australia	AU$17.03 Billion
Australian Clinical Labs Ltd AU:ACL	Australia	AU$562.50 Million

Zhejiang DiAn Diagnostics Co - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.73	2.65	1.61
Quick Ratio	2.36	2.27	1.41
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥6.72 Billion	CN¥7.07 Billion	CN¥3.59 Billion

Zhejiang DiAn Diagnostics Co - Advanced Valuation Insights

This section examines the relationship between Zhejiang DiAn Diagnostics Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.02
Latest Market Cap to Assets Ratio	0.12
Asset Growth Rate (YoY)	-8.6%
Total Assets	CN¥14.42 Billion
Market Capitalization	$1.67 Billion USD

Valuation Analysis

Below Book Valuation: The market values Zhejiang DiAn Diagnostics Co's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Zhejiang DiAn Diagnostics Co's assets decreased by 8.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Zhejiang DiAn Diagnostics Co (2008–2025)

The table below shows the annual total assets of Zhejiang DiAn Diagnostics Co from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥14.42 Billion ≈ $2.11 Billion	-8.64%
2024-12-31	CN¥15.79 Billion ≈ $2.31 Billion	-12.00%
2023-12-31	CN¥17.94 Billion ≈ $2.63 Billion	-14.80%
2022-12-31	CN¥21.06 Billion ≈ $3.08 Billion	+35.03%
2021-12-31	CN¥15.59 Billion ≈ $2.28 Billion	+25.77%
2020-12-31	CN¥12.40 Billion ≈ $1.81 Billion	+15.34%
2019-12-31	CN¥10.75 Billion ≈ $1.57 Billion	+0.79%
2018-12-31	CN¥10.67 Billion ≈ $1.56 Billion	+44.33%
2017-12-31	CN¥7.39 Billion ≈ $1.08 Billion	+29.25%
2016-12-31	CN¥5.72 Billion ≈ $836.65 Million	+149.44%
2015-12-31	CN¥2.29 Billion ≈ $335.42 Million	+106.74%
2014-12-31	CN¥1.11 Billion ≈ $162.24 Million	+36.63%
2013-12-31	CN¥811.49 Million ≈ $118.75 Million	+14.92%
2012-12-31	CN¥706.15 Million ≈ $103.33 Million	+17.56%
2011-12-31	CN¥600.69 Million ≈ $87.90 Million	+156.43%
2010-12-31	CN¥234.25 Million ≈ $34.28 Million	+31.09%
2009-12-31	CN¥178.69 Million ≈ $26.15 Million	+61.25%
2008-12-31	CN¥110.82 Million ≈ $16.22 Million	--

About Zhejiang DiAn Diagnostics Co

SHE:300244 China Diagnostics & Research

Market Cap

$1.67 Billion

CN¥11.40 Billion CNY

Market Cap Rank

#6944 Global

#1561 in China

Share Price

CN¥18.24

Change (1 day)

+0.39%

52-Week Range

CN¥13.59 - CN¥29.50

All Time High

CN¥46.17